Literature DB >> 25092555

MicroRNA-125 family members exert a similar role in the regulation of murine hematopoiesis.

Edyta E Wojtowicz1, Marta A Walasek2, Mathilde J C Broekhuis2, Ellen Weersing2, Martha Ritsema2, Albertina Ausema2, Leonid V Bystrykh2, Gerald de Haan3.   

Abstract

MicroRNAs (miRNAs) are crucial for proper functioning of hematopoietic stem and progenitor cells (HSPCs). Members of the miRNA-125 family (consisting of miR-125a, miR-125b1, and miR-125b2) are known to confer a proliferative advantage on cells upon overexpression, to decrease the rate of apoptosis by targeting proapoptotic genes, and to promote differentiation toward the myeloid lineage in mice. However, many distinct biological effects of the three miR-125 species have been reported as well. In the current study, we set out to assess whether the three miRNA-125s that carry identical seed sequences could be functionally different. Our data show that overexpression of each of the three miR-125 family members preserves HSPCs in a primitive state in vitro, results in a competitive advantage upon serial transplantation, and promotes skewing toward the myeloid lineage. All miR-125 family members decreased the pool of phenotypically defined Lin(-)Sca(+)Kit(+)CD48(-)CD150(+) long-term hematopoietic stem cells, simultaneously increasing the self-renewal activity upon secondary transplantation. The downregulation of miR-125s in hematopoietic stem cells abolishes these effects and impairs long-term contribution to blood cell production. The introduction of a point mutation within the miRNA-125 seed sequence abolishes all abovementioned effects and leads to the restoration of normal hematopoiesis. Our results show that all miR-125 family members are similar in function, they likely operate in a seed-sequence-dependent manner, and they induce a highly comparable hematopoietic phenotype.
Copyright © 2014 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25092555     DOI: 10.1016/j.exphem.2014.06.010

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  13 in total

Review 1.  The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine.

Authors:  Alireza Majdi; Javad Mahmoudi; Saeed Sadigh-Eteghad; Mehdi Farhoudi; Siamak Sandoghchian Shotorbani
Journal:  Neurol Sci       Date:  2016-06-27       Impact factor: 3.307

Review 2.  Beyond mRNA: The role of non-coding RNAs in normal and aberrant hematopoiesis.

Authors:  Mark C Wilkes; Claire E Repellin; Kathleen M Sakamoto
Journal:  Mol Genet Metab       Date:  2017-07-25       Impact factor: 4.797

3.  Hoxb5 reprogrammes murine multipotent blood progenitors into haematopoietic stem cell-like cells.

Authors:  Dehao Huang; Qianhao Zhao; Mengyun Zhang; Qitong Weng; Qi Zhang; Kaitao Wang; Fang Dong; Hui Cheng; Fangxiao Hu; Jinyong Wang
Journal:  Cell Prolif       Date:  2022-05-17       Impact factor: 8.755

4.  MicroRNAs in Control of Stem Cells in Normal and Malignant Hematopoiesis.

Authors:  Christine Roden; Jun Lu
Journal:  Curr Stem Cell Rep       Date:  2016-07-01

5.  Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors.

Authors:  Edyta E Wojtowicz; Eric R Lechman; Karin G Hermans; Erwin M Schoof; Erno Wienholds; Ruth Isserlin; Peter A van Veelen; Mathilde J C Broekhuis; George M C Janssen; Aaron Trotman-Grant; Stephanie M Dobson; Gabriela Krivdova; Jantje Elzinga; James Kennedy; Olga I Gan; Ankit Sinha; Vladimir Ignatchenko; Thomas Kislinger; Bertien Dethmers-Ausema; Ellen Weersing; Mir Farshid Alemdehy; Hans W J de Looper; Gary D Bader; Martha Ritsema; Stefan J Erkeland; Leonid V Bystrykh; John E Dick; Gerald de Haan
Journal:  Cell Stem Cell       Date:  2016-07-14       Impact factor: 24.633

6.  miR-125a-5p regulates megakaryocyte proplatelet formation via the actin-bundling protein L-plastin.

Authors:  Seema Bhatlekar; Bhanu K Manne; Indranil Basak; Leonard C Edelstein; Emilia Tugolukova; Michelle L Stoller; Mark J Cody; Sharon C Morley; Srikanth Nagalla; Andrew S Weyrich; Jesse W Rowley; Ryan M O'Connell; Matthew T Rondina; Robert A Campbell; Paul F Bray
Journal:  Blood       Date:  2020-10-08       Impact factor: 22.113

7.  miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism.

Authors:  Jun Liu; Bo Guo; Zhuo Chen; Nayi Wang; Michelina Iacovino; Jijun Cheng; Christine Roden; Wen Pan; Sajid Khan; Suning Chen; Michael Kyba; Rong Fan; Shangqin Guo; Jun Lu
Journal:  Blood       Date:  2017-01-04       Impact factor: 22.113

8.  Age-Associated Decrease of the Histone Methyltransferase SUV39H1 in HSC Perturbs Heterochromatin and B Lymphoid Differentiation.

Authors:  Dounia Djeghloul; Klaudia Kuranda; Isabelle Kuzniak; Daniela Barbieri; Irina Naguibneva; Caroline Choisy; Jean-Christophe Bories; Christine Dosquet; Marika Pla; Valérie Vanneaux; Gérard Socié; Françoise Porteu; David Garrick; Michele Goodhardt
Journal:  Stem Cell Reports       Date:  2016-06-14       Impact factor: 7.765

9.  High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.

Authors:  Elena Vendramini; Marco Giordan; Emanuela Giarin; Barbara Michielotto; Grazia Fazio; Gianni Cazzaniga; Andrea Biondi; Daniela Silvestri; Maria Grazia Valsecchi; Martina U Muckenthaler; Andreas E Kulozik; Valter Gattei; Shai Izraeli; Giuseppe Basso; Geertruy Te Kronnie
Journal:  Oncotarget       Date:  2017-06-27

Review 10.  The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy.

Authors:  Chengxin Luan; Zixue Yang; Baoan Chen
Journal:  Onco Targets Ther       Date:  2015-10-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.